Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学NK/T-Cell Lymphoma, EBV LMP1

Lihua Qiu

MD

🏢Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC🌐China

Director, Lymphoma Section

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Lihua Qiu investigates EBV-associated mechanisms in NK/T-cell lymphoma with focus on LMP1-driven NF-kB signaling and epigenetic reprogramming in EBV-positive lymphoma cells. Her translational research seeks to identify druggable vulnerabilities in EBV-driven lymphomagenesis that could be exploited with novel targeted agents. She participates in national Chinese lymphoma clinical trial networks.

Share:

🧪Research Fields 研究领域

EBV LMP1 signaling
NF-kB NK/T-cell lymphoma
EBV latency patterns NK/T
targeted therapy EBV lymphoma
EBVL treatment China

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Lihua Qiu 的研究动态

Follow Lihua Qiu's research updates

留下邮箱,当我们发布与 Lihua Qiu(Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment